Enhancement of diphtheria toxin potency by replacement of the receptor binding domain with tetanus toxin C-fragment: A potential vector for delivering heterologous proteins to neurons

被引:27
作者
Francis, JW
Brown, RH
Figueiredo, D
Remington, MP
Castillo, O
Schwarzschild, MA
Fishman, PS
Murphy, JR
vanderSpek, JC
机构
[1] Massachusetts Gen Hosp, Cecil B Day Ctr Neuromuscular Res, Dept Neurol, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Dept Neurol, Mol Neurobiol Lab, Charlestown, MA 02129 USA
[3] Harvard Univ, Sch Med, Charlestown, MA USA
[4] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[5] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA
[6] Baltimore Vet Affairs Med Ctr, Res Serv, Baltimore, MD USA
关键词
diphtheria toxin : tetanus toxin fusion protein; vector delivery system; neurons;
D O I
10.1046/j.1471-4159.2000.0742528.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study describes the expression, purification, and characterization of a recombinant fusion toxin, DAB(389)TTC, composed of the catalytic and membrane translocation domains of diphtheria toxin (DAB(389)) linked to the receptor binding fragment of tetanus toxin (C-fragment). As determined by its ability to inhibit cellular protein synthesis in primary neuron cultures, DAB(389)TTC was similar to 1,000-fold more cytotoxic than native diphtheria toxin or the previously described fusion toxin, DAB(389)MSH. The cytotoxic effect of DAB(389)TTC on cultured cells was specific toward neuronal-type cells and was blocked by coincubation of the chimeric toxin with tetanus antitoxin. The toxicity of DAB(389)TTC, like that of diphtheria toxin, was dependent on passage through an acidic compartment and ADP-ribosyltransferase activity of the DAB(389) catalytic fragment. These results suggest that a catalytically inactive form of DAB(389)TTC may be useful as a nonviral vehicle to deliver exogenous proteins to the cytosolic compartment of neurons.
引用
收藏
页码:2528 / 2536
页数:9
相关论文
共 52 条
[51]   ACTIVE-SITE MUTATIONS OF DIPHTHERIA-TOXIN - EFFECTS OF REPLACING GLUTAMIC ACID-148 WITH ASPARTIC-ACID, GLUTAMINE, OR SERINE [J].
WILSON, BA ;
REICH, KA ;
WEINSTEIN, BR ;
COLLIER, RJ .
BIOCHEMISTRY, 1990, 29 (37) :8643-8651
[52]  
YAMAZIUMI M, 1978, CELL, V14, P21940